Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

White matter and subcortical MRI markers of subsequent cognitive decline in late-life depression: A two-stage study.

Created on 02 Sep 2026

Authors

Chaoyue Guo, Yuan Fang, Qi Qiu, Lei Fan, Henry Brodaty, Perminder S Sachdev, Wei Wen, Xia Li

Published in

International psychogeriatrics. Pages 100265. Sep 01, 2026. Epub Sep 01, 2026.

Abstract

Late-life depression (LLD) is associated with increased risk of cognitive decline and dementia, yet clinically relevant neuroimaging markers of short-term cognitive decline remain uncertain.
We conducted a two-stage study. In the Shanghai Action to Prevent the Elderly from Dementia (SHAPE) cohort, baseline MRI was compared among 40 LLD participants with stable cognition (LLDcs), 38 LLD participants with cognitive decline over two years (LLDcd), and 47 healthy controls. Measures included peak width of skeletonized mean diffusivity (PSMD), global and tract-specific difference in distribution function based on mean diffusivity (DDFMD), grey-matter measures, and regional diffusion tensor image analysis along the perivascular space (ALPS) indices. Within-group partial correlations between MRI measures and cognitive performance were also examined. Candidate markers were then evaluated in the Sydney Memory and Ageing Study (MAS) LLD sample (21 LLDcs, 16 LLDcd) using SHAPE-trained single-marker Firth logistic models applied without refitting.
In SHAPE, LLDcd showed greater white-matter microstructural burden than LLDcs and controls, including higher PSMD, lower global and tract-specific DDFMD, alongside smaller left nucleus accumbens (L_NAcc) volume. Within LLDcd, poorer white-matter integrity was associated with worse orientation and other cognitive domains. In MAS, global DDFMD and L_NAcc volume were the two markers whose discrimination of LLDcd survived correction for multiple comparisons.
White-matter microstructural burden and smaller L_NAcc volume may help characterize LLD patients at higher near-term risk of cognitive decline. These findings warrant evaluation in larger longitudinal LLD cohorts.

PMID:
42680642
Bibliographic data and abstract were imported from PubMed on 02 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement